Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain.

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...